Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors

FASEB Journal

Volumn 20, Issue 6, 2006, Pages 621-630

  Dirkx, Anita E M ^a   Oude Egbrink, Mirjam G A ^b   Castermans, Karolien ^a   Van Der Schaft, Daisy W J ^a   Thijssen, Victor L J L ^a   Dings, Ruud P M ^c   Kwee, Lucy ^a   Mayo, Kevin H ^c   Wagstaff, John ^a   Bouma ter Steege, Jessica C A ^a   Griffioen, Arjan W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Anginex; Angiogenesis; Endostatin; Endothelial adhesion molecules

Indexed keywords

ANGINEX; ANGIOGENESIS INHIBITOR; ANGIOSTATIN; CD45 ANTIGEN; CELL ADHESION MOLECULE; CYCLOPHOSPHAMIDE; ENDOSTATIN; FUMAGILLOL CHLOROACETYLCARBAMATE; INTERCELLULAR ADHESION MOLECULE 1; PACLITAXEL; VASCULAR CELL ADHESION MOLECULE 1; ANTINEOPLASTIC AGENT; BETAPEP 25 PROTEIN, SYNTHETIC; BETAPEP-25 PROTEIN, SYNTHETIC; CYCLOHEXANE DERIVATIVE; O-(CHLOROACETYLCARBAMOYL)FUMAGILLOL; PROTEIN; SESQUITERPENE; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNIZATION; CANCER INHIBITION; CELL INFILTRATION; CELL INTERACTION; CLONAL ANERGY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INHIBITION KINETICS; LEUKOCYTE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR IMMUNITY; TUMOR MODEL; ANIMAL; CYTOLOGY; DOWN REGULATION; ENDOTHELIUM; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TUMOR CELL LINE; VASCULARIZATION;

ANGIOSTATINS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CLONAL ANERGY; CYCLOHEXANES; CYCLOPHOSPHAMIDE; DOWN-REGULATION; ENDOSTATINS; ENDOTHELIAL CELLS; ENDOTHELIUM; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PACLITAXEL; PROTEINS; SESQUITERPENES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33646231504     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-4493com     Document Type: Article

References (44)

1. Ribas, A., Butterfield, L. H., Glaspy, J. A., and Economou, J. S. (2003) Current developments in cancer vaccines and cellular immunotherapy. J. Clin. Oncol. 21, 2415-2432
2. Rosenberg, S. A. (2004) Shedding light on immunotherapy for cancer. N. Engl. J. Med. 350, 1461-1463
3. Dvorak, H. F. (2005) Angiogenesis: update 2005. J. Thromb. Haemost. 3, 1835-1842
4. Griffioen, A. W., and Molema, G. (2000) Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases and chronic inflammation. Pharmacol. Rev. 52, 237-268
5. Kerbel, R., and Folkman, J. (2002) Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2, 727-739
6. Griffioen, A. W., Damen, C. A., Blijham, G. H., and Groenewegen, G. (1996) Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor associated endothelium. Blood 88, 667-673
7. Griffioen, A. W., Damen, C. A., Martinotti, S., Blijham, G. H., and Groenewegen, G. (1996) Endothelial ICAM-1 expression is suppressed in human malignancies; role of angiogenic factors. Cancer Res. 56, 1111-1117
8. Piali, L., Fichtel, A., Terpe, H. J., Imhof, B. A., and Gisler, R. H. (1995) Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J. Exp. Med. 181, 811-816
9. Hellwig, S. M. M., Damen, C. A., Van Adrichem, N. P. H., Groenewegen, G., Blijham, G. H., and Griffioen, A. W. (1997) Endothelial CD34 is suppressed in human malignancies; role of angiogenic factors. Cancer Lett. 120, 203-211
10. Tromp, S. C., oude Egbrink, M. G. A., Dings, R. P. M., Van Velzen, S., Slaaf, D. W., Hillen, H. F. P., Tangelder, G. J., Reneman, R. S., and Griffioen, A. W. (2000) Tumor angiogenesis factors reduce leukocyte adhesion in vivo. Int. Immunol. 12, 671-676
11. Melder, R. J., Koenig, G. C., Witwer, B. P., Safabakhsh, N., Munn, L. L., and Jain, R. K. (1996) During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat. Med. 2, 992-997
12. Dirkx, A., oude Egbrink, M. G. A., Kuipers, M., Van de Niet, S. T., Heijnen, V. V. T., Bouma-ter Steege, J. C. M., Wagstaff, J., and Griffioen, A. W. (2003) Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res. 63, 2322-2329
13. Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med. 348, 203-213
14. Nair, S., Boczkowski, D., Moeller, B., Dewhirst, M., Vieweg, J., and Gilboa, E. (2003) Synergy between tumor immunotherapy and antiangiogenic therapy. Blood 102, 964-971
15. Niethammer, A. G., Xiang, R., Becker, J. C., Wodrich, H., Pertl, U., Karsten, G., Eliceiri, B. P., and Reisfeld, R. A. (2002) A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat. Med. 8, 1369-1375
16. Wei, Y. Q., Wang, Q. R., Zhao, X., Yang, L., Tian, L., Lu, Y., Kang, B., Lu, C. J., Huang, M. J., Lou, Y. Y., et al. (2000) Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat. Med. 6, 1160-1166
17. Van der Schaft, D. W. J., Dings, R. P. M., De Lussanet, Q. R., Van Eijk, L. I., Nap, A. W., Beets-Tan, R. G. H., Bouma-Ter Steege, J. C. A., Wagstaff, J., Mayo, K. H., and Griffioen, A. W. (2002) The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models. FASEB J. 63, 1991-1995
18. Dings, R. P. M., Yokoyama, Y., Ramakrishnan, S., Griffioen, A. W., and Mayo, K. H. (2003) The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin. Cancer Res. 63, 382-385
19. Kisker, O., Becker, C. M., Prox, D., Fannon, M., D'Amato, R., Flynn, E., Fogler, W. E., Sim, B. K., Allred, E. N., Pirie-Shepherd, S. R., et al. (2001) Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res. 61, 7669-7674
20. Wahl, M. L., Kenan, D. J., Gonzalez-Gronow, M., and Pizzo, S. V. (2005) Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated. J. Cell Biochem.
21. Folkman, J. (2002) Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29, 15-18
22. Kusaka, M., Sudo, K., Fujita, T., Marui, S., Itoh, F., Ingber, D., and Folkman, J. (1991) Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem. Biophys. Res. Commun. 174, 1070-1076
23. Satchi-Fainaro, R., Mamluk, R., Wang, L., Short, S. M., Nagy, J. A., Feng, D., Dvorak, A. M., Dvorak, H. F., Puder, M., Mukhopadhyay, D., et al. (2005) Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell 7, 251-261
24. Bocci, G., Nicolaou, K. C., and Kerbel, R. S. (2002) Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs. Cancer Res. 62, 6938-6943
25. Griffioen, A. W., Van der Schaft, D. W. J., Barendsz-Janson, A. F., Cox, A., Struijker Boudier, H. A. J., Hillen, H. F. P., and Mayo, K. H. (2001) Anginex, a designed peptide that inhibits angiogenesis. Biochem. J. 2001, 233-242
26. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328
27. Yamaoka, M., Yamamoto, T., Ikeyama, S., Sudo, K., and Fujita, T. (1993) Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res. 53, 5233-5236
28. Janssen, G. H., Tangelder, G. J., oude Egbrink, M. G., Reneman, R. S. (1994) Spontaneous leukocyte rolling in venules in untraumatized skin of conscious and anesthetized animals. Am. J. Physiol 267, H1199-H1204
29. Slaaf, D. W., Alewijnse, R., and Wayland, H. (1982) Use of telescopic imaging in intravital microscopy: a simple solution for conventional microscopes. Int. J. Microcirc. Clin. Exp. 1, 121-134
30. Thijssen, V. L. J. L., Brandwijk, R., Dings, R. P. M., and Griffioen, A. W. (2004) Angiogenesis gene expression profiling in xenograft models to study cellular interactions. Exp. Cell Res. 299, 286-293
31. Zhang, H., and Issekutz, A. C. (2002) Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668. Am. J. Pathol. 160, 2219-2230
32. Bouma-Ter Steege, J. C. A., Baeten, C. I. M., Tijssen, V. L. J. L., Satijn, S. A., Verhoeven, I. C. L., Hillen, H. F. P., Wagstaff, J., and Griffioen, A. W. (2004) Angiogenic profile of breast carcinoma determines leukocyte infiltrate. Clin. Cancer Res. 10, 7171-7178
33. Griffioen, A. W., Damen, C. A., Mayo, K., Barendsz-Janson, A. F., Martinotti, S., Blijham, G. H., and Groenewegen, G. (1999) Angiogenesis inhibitors overcome tumor induced endothelial cell anergy. Int. J. Cancer 80, 315-319
34. Luo, J., Lin, J., Paranya, G., and Bischoff, J. (1998) Angiostatin upregulates E-selectin in proliferating endothelial cells. Biochem. Biophys. Res. Commun. 245, 906-911
35. Reiss, Y., Hoch, G., Deutsch, U., and Engelhardt, B. (1998) T cell interaction with ICAM-1-deficient endothelium in vitro: essential role for ICAM-1 and ICAM-2 in transendothelial migration of T cells. Eur. J. Immunol. 28, 3086-3099
36. Griffioen, A. W. (1997) Phenotype of the tumor vasculature; cell adhesion as a target for tumor therapy. Cancer J. 10, 249-255
37. Nooijen, P. T., Westphal, J. R., Eggermont, A. M., Schalkwijk, C., Max, R., de Waal, R. M., and Ruiter, D. J. (1998) Endothelial P-selectin expression is reduced in advanced primary melanoma and melanoma metastasis. Am. J. Pathol. 152, 679-682
38. Creamer, D., Sullivan, D., Bicknell, R., and Barker, J. (2003) Angiogenesis in psoriasis. Angiogenesis 5, 231-236
39. Demaria, S., Volm, M. D., Shapiro, R. L., Yee, H. T., Oratz, R., Formenti, S. C., Muggia, F., and Symmans, W. F. (2001) Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy. Clin. Cancer Res. 7, 3025-3030
40. Ahmed, B., Van Eijk, L., Bouma-Ter Steege, J. C. A., Van der Schaft, D. W. J., Van Esch, A. M., Lambin, P., Landuijt, W., and Griffioen, A. W. (2003) A defined role of angiogenesis inhibition in the overall vascular targeting activity of combretastatin A-4 phosphate. Int. J. Cancer 104, 87-94
41. Teicher, B. A., Sotomayor, E. A., and Huang, Z. D. (1992) Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res. 52, 6702-6704
42. Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., and Hanahan, D. (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13, 1382-1397
43. Coussens, L. M., Tinkle, C. L., Hanahan, D., and Werb, Z. (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481-490
44. Leek, R. D., Lewis, C. E., Whitehouse, R., Greenall, M., Clarke, J., and Harris, A. L. (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56, 4625-4629